ライフサイエンスコーパス: fine-needle aspiration

1 r diagnostic confirmation when combined with fine needle aspiration.

2 lymph node status defined by ultrasound and fine needle aspiration.

3 mproved in resolution and ability to perform fine needle aspiration.

4 preparations obtained by minimally invasive fine needle aspiration.

5 hypothesis in people using ultrasound-guided fine needle aspiration.

6 center reactions, as assessed by lymph node fine needle aspiration.

7 oid compression source were performed before fine-needle aspiration.

8 adiologic evaluations, and early performance fine-needle aspiration.

9 ther than in tissue removed surgically or by fine-needle aspiration.

10 nce metrics between TTMV-HPV DNA testing and fine-needle aspiration.

11 fluid samples obtained by ultrasound-guided fine-needle aspiration.

12 us harms from screening or ultrasound-guided fine-needle aspiration.

13 tment is currently done on tumor biopsies or fine-needle aspirations.

14 core-needle biopsy (50% [17/34] P = .04) and fine needle aspiration (0% [0/2]; P = .009).

15 e procured with endoscopic ultrasound-guided fine-needle aspiration 1 week before and 2 weeks after c

16 multicentric breast lesions proven by either fine-needle aspiration (19/59), core biopsy (39/59), or

17 ), and set 2-95 endoscopic ultrasound-guided fine-needle aspirations (60 PDAC, 9 IPMN, 26 C).

18 ion (93%), and ultrasound guided parathyroid fine needle aspiration (78%).

19 6 of 170 patients who underwent preoperative fine-needle aspiration (91.8%), a benign tumor was diagn

20 In the present study, we used fine-needle aspiration (a nonterminal sampling method) t

21 the combination of endoscopic ultrasound and fine-needle aspiration analysis for KIT expression may b

22 le to clinical samples, including cells from fine needle aspiration and tissues obtained via core nee

23 ules that are cytologically indeterminate on fine-needle aspiration and benign according to gene-expr

24 Fine-needle aspiration and biopsy of bone led to reduced

25 In patients undergoing both fine-needle aspiration and biopsy, the former proved dia

26 suspected to be an infected parasitic cyst; fine-needle aspiration and cytology were not attempted d

27 practical obstacles of liver sampling using fine-needle aspiration and develop an optimized workflow

28 Both fine-needle aspiration and intraoperative frozen section

29 less invasive techniques such as testicular fine-needle aspiration and percutaneous needle biopsy ar

30 P and may provide a tissue diagnosis through fine-needle aspiration and staging through ultrasound im

31 ence of ductal carcinoma-in-situ, the use of fine-needle aspiration and stereotactic biopsy for diagn

32 which can improve the diagnostic accuracy of fine-needle aspirations and provide prognostic informati

33 l image analysis, endoscopic ultrasound with fine needle aspiration, and cholangioscopy.

34 We performed fine needle aspiration, and demonstrate that severe acut

35 reoperative studies such as ultrasonography, fine-needle aspiration, and better molecular and genetic

36 h unnecessary workup in the form of imaging, fine-needle aspiration, and diagnostic surgery.

37 )C-methionine PET/CT, MRI, ultrasound-guided fine-needle aspiration, and selective venous sampling fo

38 Endoscopy and endoscopic ultrasound-guided, fine-needle aspiration are key components in the diagnos

39 30% of thyroid nodules evaluated by means of fine-needle aspiration are not clearly benign or maligna

40 Pancreatic fine-needle aspirations are the gold-standard diagnostic

41 pic biopsies, and endoscopic ultrasound with fine-needle aspiration at regular intervals.

42 Herein, through a fine-needle aspiration-based approach, we profiled the i

43 ical problems such as the suspicious thyroid fine needle aspiration, better treatment algorithms for

44 chnology now allow the detection of these in fine needle aspiration biopsies (FNA).

45 n 8 patients, paired diagnostic transscleral fine needle aspiration biopsies were performed using bot

46 ch limits its access to isolated rare cells, fine needle aspiration biopsies, and tissue substructure

47 orphological evaluation can be acquired with fine-needle aspiration biopsies (FNAB) controlled with C

48 isk of malignancy is cytologic evaluation of fine-needle aspiration biopsies (FNABs).

49 ression data (gene chips) was generated from fine-needle aspiration biopsies (n = 229) prospectively

50 trations of human Tg from needle washouts of fine-needle aspiration biopsies of thyroid nodule from d

51 S) aims to standardise assessment and reduce fine-needle aspiration biopsies through risk stratificat

52 A total of 209 fine-needle aspiration biopsies were performed on 156 pa

53 m tumors were conducted and compared with 86 fine-needle aspiration biopsies(FNAB) of lung and medias

54 ee detection of Tg in the needle washouts of fine-needle aspiration biopsies, at concentrations usefu

55 F4a) applied to endoscopic ultrasound-guided fine needle aspiration biopsy (EUS-FNAB) materials.

56 Serum, liver fine needle aspiration biopsy (FNA), and liver core need

57 The majority of nodules with fine needle aspiration biopsy (FNAB) results that are cl

58 Perform the first in vivo examination of fine needle aspiration biopsy (FNAB) scleral tracts to d

59 th both ultrasonography (US) and US-assisted fine needle aspiration biopsy (FNAB).

60 e diagnosis was made using ultrasound-guided fine needle aspiration biopsy and consequent cytopatholo

61 pplied to improve the diagnostic accuracy of fine needle aspiration biopsy and cytologic examination.

62 d Epidemiology, Initial Evaluation, Imaging, Fine Needle Aspiration Biopsy Diagnosis, Molecular Testi

63 d Epidemiology, Initial Evaluation, Imaging, Fine Needle Aspiration Biopsy Diagnosis, Molecular Testi

64 Mutation analysis in thyroid nodule fine needle aspiration biopsy has been applied to improv

65 iomarkers that could improve the accuracy of fine needle aspiration biopsy in the evaluation of patie

66 in one patient and a percutaneous CT-guided fine needle aspiration biopsy in the other disclosed nor

67 l line were originated simultaneously from a fine needle aspiration biopsy of a metastasis in a patie

68 etrieve lower respiratory tract samples; and fine needle aspiration biopsy of lymph nodes.

69 Fine needle aspiration biopsy of tumors was done at base

70 d cancer that are beginning to be applied in fine needle aspiration biopsy samples to improve diagnos

71 Fine needle aspiration biopsy was done and revealed no a

72 utting needle was utilized in 124 cases, and fine needle aspiration biopsy was performed in 14 cases.

73 differential diagnosis of thyroid tumors by fine needle aspiration biopsy, specifically suspicious o

74 d non-diagnostic results or spindle cells on fine needle aspiration biopsy.

75 lly or histologically proved after US-guided fine-needle aspiration biopsy (eight lesions) or core bi

76 Endosonography-guided fine-needle aspiration biopsy (EUS-FNA) permits cytologi

77 s with posterior uveal melanoma evaluated by fine-needle aspiration biopsy (FNAB) at the time of or s

78 Fine-needle aspiration biopsy (FNAB) for DNA amplificati

79 In Lusaka, Zambia, we introduced liver fine-needle aspiration biopsy (FNAB) into a research coh

80 Fine-needle aspiration biopsy (FNAB) of tumor for DNA am

81 most potentially devastating complication of fine-needle aspiration biopsy (FNAB) or open biopsy is e

82 utility of BRAF mutation testing of thyroid fine-needle aspiration biopsy (FNAB) specimens for preop

83 Use of fine-needle aspiration biopsy (FNAB) specimens on Xpert

84 Thyroid fine-needle aspiration biopsy (FNAB) specimens were anal

85 ied TCGA classification to UM biopsied using fine-needle aspiration biopsy (FNAB) to determine the pr

86 9 to July 2013 who underwent prognostication fine-needle aspiration biopsy (FNAB) were included.

87 r (p < 0.01) and those involved with thyroid fine-needle aspiration biopsy (p < 0.01).

88 w curved linear-array instruments, real-time fine-needle aspiration biopsy (RTFNA) of pancreatic lesi

89 8q, as well as sex, source of tumor tissue (fine-needle aspiration biopsy [FNAB] compared with tumor

90 Fine-needle aspiration biopsy also allows characterizati

91 te thyroid nodules; and peripheral blood and fine-needle aspiration biopsy analysis of molecular mark

92 Fine-needle aspiration biopsy and core biopsy are import

93 ar period who were evaluated with prognostic fine-needle aspiration biopsy at the time of primary tre

94 with uveal melanoma who underwent prognostic fine-needle aspiration biopsy at the time of primary tre

95 Percutaneous fine-needle aspiration biopsy can be used for the diagno

96 Fine-needle aspiration biopsy confirmed the diagnoses (n

97 Clear corneal fine-needle aspiration biopsy confirmed the diagnosis as

98 versely, some population-based studies using fine-needle aspiration biopsy data report no linkage bet

99 The preferred approach when repeated fine-needle aspiration biopsy fails to yield an adequate

100 5 brachytherapy and underwent intraoperative fine-needle aspiration biopsy for cytopathology and uvea

101 Fine-needle aspiration biopsy for metastatic prognostica

102 Fine-needle aspiration biopsy for prognostication in cho

103 Core-needle biopsy in comparison to fine-needle aspiration biopsy has more frequent rate of

104 Fine-needle aspiration biopsy has resulted in substantia

105 Fine-needle aspiration biopsy identifies the childhood t

106 US-guided fine-needle aspiration biopsy is a simple, rapid, inexpe

107 Fine-needle aspiration biopsy is an alternative to open

108 Fine-needle aspiration biopsy is both accurate and cost-

109 Fine-needle aspiration biopsy is more reliable in distin

110 Fine-needle aspiration biopsy is not perfect and adjunct

111 Tissue sampling with fine-needle aspiration biopsy is recommended.

112 Fine-needle aspiration biopsy is the standard diagnostic

113 Fine-needle aspiration biopsy MT for BRAF, RAS, PAX8-PPA

114 0 for "highly suggestive of malignancy." For fine-needle aspiration biopsy of a palpable lump perform

115 The diagnosis was made by fine-needle aspiration biopsy of a pulmonary nodule.

116 Fine-needle aspiration biopsy of choroidal melanoma offe

117 ry 2012 to December 2014 from intraoperative fine-needle aspiration biopsy of choroidal tumors underg

118 Fine-needle aspiration biopsy of large thyroid nodules h

119 d ultrasonography and ultrasonography-guided fine-needle aspiration biopsy of nodules at least 1 cm i

120 ltrasound imaging, thyroid scintigraphy, and fine-needle aspiration biopsy of nodules with certain ul

121 nodes and as a guidance system for directed fine-needle aspiration biopsy of suspicious lesions.

122 Ultrasound (US)-guided fine-needle aspiration biopsy of the largest node reveal

123 Ultrasonography (US)-guided fine-needle aspiration biopsy of the left anterior chest

124 l melanoma may be directed by the results of fine-needle aspiration biopsy of the primary tumor.

125 patients who underwent surgical resection or fine-needle aspiration biopsy of the suspected hyperfunc

126 r vitrectomy followed by transvitrector port fine-needle aspiration biopsy of the tumor immediately b

127 abilities, either computed tomography-guided fine-needle aspiration biopsy or positron emission tomog

128 16 of 680) of malignancies would not undergo fine-needle aspiration biopsy or surgery if the SRU guid

129 Either fine-needle aspiration biopsy or ultrasonography is reco

130 Secondary outcomes included nodule fine-needle aspiration biopsy rate and physician-reporte

131 oid cancer incidence is increasing, and when fine-needle aspiration biopsy results are cytologically

132 tive review of 2,988 consecutive stereotaxic fine-needle aspiration biopsy samples of nonpalpable bre

133 MN/CA9 protein in histological sections and fine-needle aspiration biopsy smears of normal kidney, b

134 an algorithm for prospective MT of in-house fine-needle aspiration biopsy specimens, we conducted a

135 ly can augment the diagnostic specificity of fine-needle aspiration biopsy to better differentiate cy

136 Fine-needle aspiration biopsy was used in 10 cases and c

137 at, gray-scale thyroid ultrasonography and a fine-needle aspiration biopsy were performed.

138 In fact, AFTNs can be safely excluded from fine-needle aspiration biopsy while either (99m)Tc-metho

139 ary nodal metastases confirmed by results of fine-needle aspiration biopsy who had a clip placed in t

140 on was confirmed with MRI, PET/CT, CT-guided fine-needle aspiration biopsy, and fluoroscopy-guided pe

141 sibly followed by computed tomography-guided fine-needle aspiration biopsy, is best.

142 Studies were included if 1) mammography, fine-needle aspiration biopsy, or core-needle biopsy was

143 onography (US)-guided core biopsy, US-guided fine-needle aspiration biopsy, surgical excision, and mu

144 ture of thyroid abscess material obtained by fine-needle aspiration biopsy.

145 ion for thyroid nodules is ultrasound-guided fine-needle aspiration biopsy.

146 of nodules with inconclusive findings after fine-needle aspiration biopsy.

147 ere found to be papillary thyroid cancers at fine-needle aspiration biopsy.

148 st studies, nodule cytology was evaluated by fine-needle aspiration biopsy.

149 graphic follow-up had been recommended after fine-needle aspiration biopsy.

150 important issue undermining the benefits of fine-needle aspiration biopsy.

151 Endoscopic ultrasound-fine needle aspiration can be helpful in detecting local

152 characteristics plus follow-up cytology from fine-needle aspiration can identify thyroid cancers, it

153 In addition, liver fine-needle aspirations captured a heterogeneous liver m

154 In 138 (66%), findings at previous fine-needle aspiration cytologic (FNAC) analysis were no

155 Fine-needle aspiration cytologic biopsy and 6 months of

156 Diagnosis is based on fine-needle aspiration cytologic examination.

157 mode of diagnosis, thus avoiding unnecessary fine needle aspiration cytologies.

158 w dominated by the application of EUS-guided fine needle aspiration cytology (EUS-FNA), and the newes

159 ent endoscopic ultrasound (EUS) with/without fine needle aspiration cytology (FNAC) and were followed

160 id nodules frequently require ultrasound and Fine Needle Aspiration Cytology (FNAC) evaluation.

161 Thyroid fine needle aspiration cytology (FNAC) is the standard d

162 Fine needle aspiration cytology is central to the evalua

163 d nodules 1 cm or larger with ultrasound and fine-needle aspiration cytology (FNA).

164 classification provides recommendations for fine-needle aspiration cytology (FNAC) based on objectiv

165 als on the benefit of US elastography-guided fine-needle aspiration cytology (FNAC) over conventional

166 er axillary ultrasound (AUS) after NAC after fine-needle aspiration cytology can identify abnormal no

167 section.Preoperative axillary ultrasound and fine-needle aspiration cytology has recently been shown

168 laparoscopy, endoscopic ultrasonography, and fine-needle aspiration cytology to identify 38 patients

169 the basis of the imaging findings, US-guided fine-needle aspiration cytology was performed to confirm

170 of which lesions should be followed without fine-needle aspiration cytology.

171 n age of 55 years (range, 23-85 years) and a fine-needle aspiration diagnosis of atypia of undetermin

172 e, extrathyroidal extension, or a definitive fine-needle aspiration diagnosis.

173 al and who were led to surgical resection or fine-needle aspiration due to suspicious clinical, labor

174 nt by excisional biopsy material rather than fine needle aspiration, due to propensity for focal invo

175 EUS, EUS-guided fine needle aspiration (EUS-fine needle aspiration), emerging cytologic markers obta

176 gs regarding the accuracy of EUS, EUS-guided fine needle aspiration (EUS-fine needle aspiration), eme

177 The usage of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for the diagnosis of so

178 undergoing endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) of pancreatic cysts, bu

179 ously undergone Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) or ERCP brush cytology

180 atic disease, and endoscopic ultrasound with fine needle aspiration (EUS-FNA) remain the preferred me

181 EBUS-TBNA, then endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) was allowed as an alter

182 Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) was evaluated as a sing

183 hat obtained by endoscopic ultrasound-guided fine needle aspiration (EUS-FNA), currently considered t

184 The role of EUS-guided fine-needle aspiration (EUS FNA) in this setting is uncl

185 diagnosed by endoscopic, ultrasound-guided, fine-needle aspiration (EUS-FNA) biopsy and were resecte

186 urs obtained by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for diagnosis of metast

187 rrent guidelines, endoscopic ultrasound with fine-needle aspiration (EUS-FNA) is recommended in pancr

188 Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA), the most sensitive dia

189 sive technique (endoscopic ultrasound-guided fine-needle aspiration [EUS-FNA]) is capable of sampling

190 Fine needle aspiration (FNA) biopsy of thyroid nodules i

191 erminate or suspicious cytologic features on fine needle aspiration (FNA) biopsy require thyroidectom

192 A similar ex vivo analysis was performed on fine needle aspiration (FNA) biopsy samples from four mu

193 The molecular work-up of thyroid nodules on fine needle aspiration (FNA) cytology samples has given

194 t the utility of endoscopic ultrasound (EUS)/fine needle aspiration (FNA) for detection of MRLNs in e

195 Subsequent diagnostics included fine needle aspiration (FNA) of suspicious lesions and m

196 We amplified RNAs from 63 fine needle aspiration (FNA) samples from 37 s.c. melano

197 f malignant lesions in vivo while performing fine needle aspiration (FNA).

198 n be detected and sampled effectively by EUS-fine needle aspiration (FNA).

199 One-time evaluation with fine-needle aspiration (FNA) and combinations of chemica

200 Clinical specimens obtained through fine-needle aspiration (FNA) and excisional biopsy were

201 ve consecutive case series and GC testing of fine-needle aspiration (FNA) and formalin-fixed paraffin

202 uary 2016 to April 2022 and residual thyroid fine-needle aspiration (FNA) biopsies obtained from Janu

203 t an estimated 30% of ultrasonography-guided fine-needle aspiration (FNA) biopsies of thyroid nodules

204 patients younger than 19 years who underwent fine-needle aspiration (FNA) biopsy between January 2004

205 nd a separate cohort of 217 residual thyroid fine-needle aspiration (FNA) biopsy specimens obtained f

206 appropriate clinical workup with imaging and fine-needle aspiration (FNA) biopsy to evaluate for canc

207 computed tomography (CT)-guided percutaneous fine-needle aspiration (FNA) has become the procedure of

208 ntly, endobronchial ultrasound-guided (EBUS) fine-needle aspiration (FNA) has become the standard of

209 Fine-needle aspiration (FNA) is increasing in popularity

210 specificity of ultrasonographic (US)-guided fine-needle aspiration (FNA) of axillary lymph nodes for

211 CT-guided fine-needle aspiration (FNA) of lung lesions is subject

212 Fine-needle aspiration (FNA) of thyroid nodules has beco

213 Fine-needle aspiration (FNA) or stereotactic core biopsy

214 Data from 195 fine-needle aspiration (FNA) samples were used to define

215 cer, and molecular testing of thyroid nodule fine-needle aspiration (FNA) specimens has been proposed

216 hologic staging can be achieved at EUS using fine-needle aspiration (FNA) to obtain cytology from sus

217 rough the combination of imaging and guided, fine-needle aspiration (FNA).

218 stics of thyroid bed lesions; and results of fine-needle aspiration (FNA).

219 are not simple cysts should be studied with fine-needle aspiration (FNA).

220 undergoing endoscopic ultrasonography (EUS) fine-needle aspiration (FNA).

221 Computed tomography-guided fine-needle aspiration for Gram stain and cultures is un

222 Cytological study of EUS-guided fine needle aspiration from the mass was suggestive of s

223 ed TAA expression in metastases by obtaining fine-needle aspirations from 52 tumor lesions in 30 pati

224 The evaluation of thyroid nodules by fine-needle aspiration has been the standard for almost

225 ews the role of endoscopic ultrasound-guided fine-needle aspiration in diagnosing various pancreatic

226 psy has largely replaced fluoroscopic-guided fine-needle aspiration in PTLB.

227 thyroid nodule undergoing ultrasound-guided fine-needle aspiration in Shahid Beheshti teaching hospi

228 nostic yield of endoscopic ultrasound-guided fine needle aspiration include performing cyst wall cyto

229 biopsies and endoscopic ultrasonography with fine-needle aspiration initially declining or accepting

230 doscopic characterization of the lesion with fine needle aspiration is critical for treatment decisio

231 Endoscopic ultrasound-guided fine needle aspiration is generally adequate for tissue

232 Lymph node fine-needle aspiration is positive for malignant cells.

233 e evaluation by endoscopic ultrasound-guided fine needle aspiration may further expand the role of en

234 Mediastinal lymph node fine needle aspiration (MLN-FNA) is a common procedure;

235 tissue sampling with core-needle (n = 6) or fine-needle aspiration (n = 20) biopsy, corticosteroid o

236 Diagnosis was established with fine-needle aspiration (n = 55), 14-gauge core-needle bi

237 offering RFA included nodules with 2 benign fine-needle aspirations, no suspicious ultrasonography f

238 Fine needle aspiration of a right axillary node confirme

239 We show that fine needle aspiration of cancer provides a fast and eff

240 We used fine needle aspiration of draining lymph nodes to longit

241 Fine needle aspiration of the mass suggested a diagnosis

242 gery, determined by clinical examination and fine needle aspiration of the seroma fluid if clinically

243 g by facilitating tissue acquisition through fine needle aspiration of the tumor and surrounding lymp

244 grade 2 of 3 on core biopsy, with a positive fine-needle aspiration of a palpable, ipsilateral axilla

245 Using fine-needle aspiration of draining axillary lymph nodes

246 applied minimally invasive ultrasound-guided fine-needle aspiration of the LN to a before-and-after s

247 CT-guided fine-needle aspiration of the splenic lesion was perform

248 graphy and endoscopic ultrasonography-guided fine-needle aspiration offer high diagnostic ability for

249 Fine-needle aspiration or biopsy of all the lesions was

250 re collected by endoscopic ultrasound-guided fine-needle aspiration or surgery and were preserved as

251 in patients referred for US with subsequent fine-needle aspiration or with surgical histologic analy

252 sed to evaluate endoscopic ultrasound-guided fine-needle aspiration pancreatic cyst fluid from 31 ins

253 ity, and accuracy of EBUS and CT-scan versus fine needle aspiration pathology results were determined

254 d malignancy, the need for ultrasound-guided fine needle aspiration, preoperative staging, lymph node

255 hemistry were performed on all patients, and fine-needle aspiration procedures were performed on susp

256 The finding of a follicular neoplasm on fine-needle aspiration prompts many surgeons to perform

257 e RS, and 148 patients (3.7%) had biopsy- or fine-needle aspiration-proven RS.

258 vacuum assisted needle biopsy, image-guided fine needle aspiration, punch biopsy, and open surgical

259 jects scheduled for surgery after a previous fine-needle aspiration report of "atypia of undetermined

260 Pancreatic endoscopic ultrasound with fine needle aspiration revealed cytomorphologic features

261 ngitudinally collected blood and draining LN fine needle aspiration samples before and after SARS-CoV

262 n), emerging cytologic markers obtained from fine needle aspiration samples, and the role of EUS scre

263 lar analysis of endoscopic ultrasound-guided fine-needle aspiration samples has the potential to impr

264 amples, to predict chemotherapy responses in fine-needle aspiration samples in neoadjuvant chemothera

265 these miRNAs in endoscopic ultrasound-guided fine-needle aspiration samples makes them good biomarker

266 Fine needle aspiration should be considered in adolescen

267 ients with a solitary thyroid nodule in whom fine-needle aspiration showed a follicular neoplasm.

268 her enhanced by the ability to obtain guided fine needle aspiration specimens for cytology from any s

269 erformed with oligonecleotide microarrays on fine-needle aspiration specimens.

270 bulin antibodies, positive results on recent fine-needle aspiration, suspected enlarging mass, and ab

271 ere is controversy regarding the role of EUS fine-needle aspiration, the findings of which may enhanc

272 Fine-needle aspiration, the presence of extraintestinal

273 scan with intravenous contrast and possible fine needle aspiration to detect the presence of sterile

274 Here we used ultrasound-guided fine needle aspiration to serially sample the draining l

275 performed longitudinal liver sampling using fine-needle aspiration to investigate mechanisms of CHB

276 size, presence of cystic or necrotic nodes, fine needle aspiration, tobacco or alcohol exposure, pat

277 Although no difference was found for fine-needle aspiration versus core biopsy of malignant l

278 Hepatic fine needle aspiration was performed before treatment an

279 Ultrasound-guided fine needle aspiration was well-tolerated by all partici

280 EUS-guided fine-needle aspiration was performed on sites that were

281 nal and incisional biopsies, core needle and fine needle aspiration were 12% (PR, 0.88; 95% CI, 0.81-

282 Blood and liver fine-needle aspirations were collected, and cellular and